NaviGate Cardiac Structures, Inc. Reports “Exceptional” Six-Week Results for Two Implantations of Its GATE™ Atrioventricular Valved Stent (AVS)


Nov 29, 2017   •  Business Wire

LAKE FOREST, Calif. — NaviGate Cardiac Structures Inc. ("NCSI") announced today "exceptional results" for implantation of its GATE™ catheter-guided tricuspid atrioventricular valved stent (AVS) at six-week follow-up in two nonagenarian patients presenting with severe tricuspid valve insufficiency. Implantations of the GATE™ AVS were performed at New York-Presbyterian/Columbia University…

View Press Release

FOR IMMEDIATE RELEASE - Contact: Ronald Trahan, APR, Ronald Trahan Associates, 1 (508) 359-4005, x108